Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Allica Bank is a fintech company that delivers digital banking services for small and medium-sized businesses.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Deep Fission is transforming the energy landscape by installing modular nuclear power reactors a mile deep.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Finance of America Companies is a consumer lending company that offers lending products and services.
Coremont provides web-based portfolio management technology and outsourced services.
Clio provides cloud-based legal practice management software, helping law firms manage cases, billing, and client relationships.
Point is a home equity platform that allows homeowners to convert a portion of their home equity into cash without taking on a loan.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Wrench Group offers home repair, replacement and maintenance services specializing in heating and ventilation.
Klaviyo is an automation and email platform designed to help grow businesses.
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Blue Owl has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Blue Owl's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma. The firm invests across 38 different industry categories.
Among tracked funding rounds, Wrench Group received $1.3B in a Debt Financing round. Blue Owl's total known invested capital is $39.6B.
Blue Owl's average investment size is $629.1M across its portfolio of 68 companies.
Recent Blue Owl portfolio additions include Pyxis Oncology, MapLight Therapeutics, BridgeBio, Neuron23, Celcuity. These companies were founded in 2020 or later.